UnitedHealth Group Incorporated (NYSE:UNH) Shares Sold by Eads & Heald Wealth Management

Eads & Heald Wealth Management cut its position in shares of UnitedHealth Group Incorporated (NYSE:UNH) by 0.9% during the 4th quarter, HoldingsChannel.com reports. The firm owned 4,857 shares of the healthcare conglomerate’s stock after selling 45 shares during the period. UnitedHealth Group accounts for 1.2% of Eads & Heald Wealth Management’s investment portfolio, making the stock its 23rd biggest position. Eads & Heald Wealth Management’s holdings in UnitedHealth Group were worth $2,457,000 at the end of the most recent quarter.

A number of other institutional investors and hedge funds also recently modified their holdings of the business. Kathleen S. Wright Associates Inc. acquired a new position in UnitedHealth Group in the third quarter valued at approximately $27,000. Global Wealth Strategies & Associates grew its stake in UnitedHealth Group by 152.4% during the 3rd quarter. Global Wealth Strategies & Associates now owns 53 shares of the healthcare conglomerate’s stock worth $31,000 after buying an additional 32 shares during the last quarter. West Financial Advisors LLC bought a new stake in UnitedHealth Group in the third quarter valued at $32,000. Quarry LP increased its holdings in shares of UnitedHealth Group by 132.1% in the 2nd quarter. Quarry LP now owns 65 shares of the healthcare conglomerate’s stock worth $33,000 after acquiring an additional 37 shares during the period. Finally, RPg Family Wealth Advisory LLC acquired a new position in UnitedHealth Group during the 3rd quarter valued at about $37,000. 87.86% of the stock is owned by institutional investors and hedge funds.

UnitedHealth Group Price Performance

NYSE UNH opened at $524.78 on Wednesday. The company has a quick ratio of 0.91, a current ratio of 0.83 and a debt-to-equity ratio of 0.74. UnitedHealth Group Incorporated has a 12-month low of $436.38 and a 12-month high of $630.73. The company has a 50 day moving average price of $547.07 and a two-hundred day moving average price of $563.84. The stock has a market capitalization of $482.95 billion, a PE ratio of 33.86, a price-to-earnings-growth ratio of 1.38 and a beta of 0.62.

UnitedHealth Group (NYSE:UNH) last released its quarterly earnings results on Thursday, January 16th. The healthcare conglomerate reported $6.81 earnings per share (EPS) for the quarter, topping the consensus estimate of $6.74 by $0.07. The company had revenue of $100.81 billion during the quarter, compared to the consensus estimate of $101.60 billion. UnitedHealth Group had a return on equity of 26.69% and a net margin of 3.60%. The firm’s revenue was up 6.8% on a year-over-year basis. During the same quarter in the prior year, the company posted $5.83 EPS. As a group, equities analysts predict that UnitedHealth Group Incorporated will post 29.77 earnings per share for the current fiscal year.

UnitedHealth Group Dividend Announcement

The firm also recently disclosed a quarterly dividend, which was paid on Tuesday, December 17th. Investors of record on Monday, December 9th were given a dividend of $2.10 per share. The ex-dividend date of this dividend was Monday, December 9th. This represents a $8.40 annualized dividend and a dividend yield of 1.60%. UnitedHealth Group’s dividend payout ratio is presently 54.19%.

Analyst Ratings Changes

Several brokerages have recently issued reports on UNH. Deutsche Bank Aktiengesellschaft boosted their price objective on UnitedHealth Group from $595.00 to $625.00 and gave the stock a “buy” rating in a research report on Tuesday, December 3rd. UBS Group lowered their price target on UnitedHealth Group from $680.00 to $650.00 and set a “buy” rating on the stock in a report on Wednesday, October 16th. Truist Financial lowered their target price on shares of UnitedHealth Group from $625.00 to $610.00 and set a “buy” rating on the stock in a research note on Monday, January 6th. Barclays decreased their price objective on shares of UnitedHealth Group from $655.00 to $642.00 and set an “overweight” rating for the company in a report on Friday, January 17th. Finally, Morgan Stanley lowered their price target on UnitedHealth Group from $615.00 to $610.00 and set an “overweight” rating on the stock in a research report on Wednesday, October 16th. Two research analysts have rated the stock with a hold rating, nineteen have given a buy rating and two have assigned a strong buy rating to the company. According to data from MarketBeat.com, the stock currently has a consensus rating of “Buy” and an average target price of $627.74.

UnitedHealth Group Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.